Kalra, PR, Moon, J and Coats, AJ (2002) Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? American Heart Journal, 85 (2-3). pp. 195-197. ISSN 1097-6744
Full text not available from this repository.Item Type: | Article |
---|---|
Faculty \ School: | |
Depositing User: | EPrints Services |
Date Deposited: | 25 Nov 2010 11:13 |
Last Modified: | 23 Oct 2022 19:33 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/15443 |
DOI: |
Actions (login required)
![]() |
View Item |